A Study of ORX750 in Participants With Narcolepsy and Idiopathic Hypersomnia

PHASE2RecruitingINTERVENTIONAL
Enrollment

96

Participants

Timeline

Start Date

December 23, 2024

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
Narcolepsy Type 1Narcolepsy Type 2Idiopathic Hypersomnia
Interventions
DRUG

ORX750

ORX750 capsule.

DRUG

Placebo

ORX750 matching placebo capsule.

Trial Locations (28)

19090

RECRUITING

Willow Grove, Pennsylvania, Willow Grove

28037

RECRUITING

Denver, North Carolina, Denver

28078

RECRUITING

Huntersville, North Carolina, Huntersville

29201

RECRUITING

Columbia, South Carolina, Columbia

29406

RECRUITING

North Charleston, South Carolina, North Charleston

30274

RECRUITING

Riverdale, Georgia, Riverdale

30281

RECRUITING

Atlanta, Georgia, Atlanta

30328

RECRUITING

Atlanta, Georgia, Atlanta

32789

RECRUITING

Winter Park, Florida, Winter Park

32807

RECRUITING

Orlando, FL, Orlando

33155

RECRUITING

Miami, Florida, Miami

33176

RECRUITING

Miami, Florida, Miami

33511

RECRUITING

Brandon, Florida, Brandon

36832

RECRUITING

Auburn, Alabama, Auburn

43017

RECRUITING

Dublin, Ohio, Dublin

45245

RECRUITING

Cincinnati, Ohio, Cincinnati

48075

RECRUITING

Southfield, Michigan, Southfield

48314

RECRUITING

Sterling Heights, Michigan, Sterling Heights

70127

RECRUITING

New Orleans, Louisiana, New Orleans

78229

RECRUITING

San Antonio, Texas, San Antonio

78731

RECRUITING

Austin, Texas, Austin

85224

RECRUITING

Chandler, Arizona, Chandler

85253

RECRUITING

Scottsdale, Arizona, Scottsdale

89052

RECRUITING

Henderson, Nevada, Henderson

90805

RECRUITING

Long Beach, California, Long Beach

92705

RECRUITING

Santa Ana, California, Santa Ana

02459

RECRUITING

Newton, Massachusetts, Newton

M5S 3A3

RECRUITING

Toronto, Ontario, Toronto

All Listed Sponsors
lead

Centessa Pharmaceuticals (UK) Limited

INDUSTRY